Mint Tower Capital Management’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Mint Tower Capital Management’s Portfolio FLACU Stock Details FLACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-19,600	Closed	-$199K	–	587
2022 Q3	$199K	Hold	19,600	–	–	0.02%	386
2022 Q2	$193K	Hold	19,600	–	–	0.02%	338
2022 Q1	$196K	Hold	19,600	–	–	0.02%	281
2021 Q4	$194K	Hold	19,600	–	–	0.02%	284
2021 Q3	$197K	Hold	19,600	–	–	0.03%	266
2021 Q2	$197K	Hold	19,600	–	–	0.01%	290
2021 Q1	$199K	Sell	19,600 -5,400	-22%	-$57.6K	0.02%	284
2020 Q4	$3K	Buy	+25,000	New	+$261K	﹤0.01%	241

Mint Tower Capital Management's FLACU Position: Q4 2022 in Review

Mint Tower Capital Management sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q4 2022, closing a stake of 19,600 shares — an estimated $199K sold.

Mint Tower Capital Management first reported a position in FLACU in Q4 2020 and held it in 8 quarters. The position peaked at $199K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLACU as of Q4 2022.

Mint Tower Capital Management reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q4 2022 after selling out during the quarter.
Mint Tower Capital Management sold 19,600 Frazier Lifesciences Acquisition Corporation Unit shares in Q4 2022, an estimated $199K.
Mint Tower Capital Management first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 8 quarters.
Mint Tower Capital Management's Frazier Lifesciences Acquisition Corporation Unit position peaked at $199K in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q4 2022.

Based on Mint Tower Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.